23948sdkhjf
Log in or create to bookmark articles
Get access to all content on Life Science Focus
No commitment or card information required
Applies to personal subscription only.
Contact us for a enterprise solution.
Advertisement
Advertisement

AI drug delevoper raises USD 5bn in new round

The British AI drug developer Isomorphic Labs has raised USD 5 billion in an oversubscribed Series C founding round.
Advertisement

The financing round for Isomorphic, who specializes in developing drugs through artificial intelligence, was led by investors Greenoaks and Sequioa Capital.

Isomorphic Labs Drug Design Engine (IsoDDE) is a system to simulate different AI models, with the ambition of developing drugs to multiple therapeutic areas. The AI models are combined with the company's researchers to optimise the AI-development into potential candidates.

Advertisement Advertisement
BREAKING
{{ article.headline }}
0.108|